Figure 3
The distribution of timing of HCV RNA undetectable after the initiation of treatment at weeks 2, 4, 8, and 12 in comparison with TaqMan and qualitative Amplicor assays. SVR, sustained virological response.
Figure 3 | BMC Gastroenterology